Liras GTN 2.6 Tablet CR is used to treat and prevent heart-related chest pain (angina). Angina occurs when the heart muscle is not getting enough blood. This medicine works by relaxing and widening blood vessels so blood can flow more easily to the heart.

Liras GTN 2.6 Tablet CR is used to treat chest pain and also to promote healing of skin tear in the back passage

Uses of Liras GTN Tablet CR

Treatment of Angina

Benefits of Liras GTN Tablet CR

In Treatment of Angina

Liras GTN 2.6 Tablet CR helps in prevention as well as treatment of angina. Angina is a chest pain that is usually caused by narrowing of the blood vessels which supply your heart. This means your heart does not get enough oxygen. Liras GTN 2.6 Tablet CR works quickly to relax the muscles and blood vessels in your heart so more blood (and oxygen) gets to your heart. This reduces the pain and discomfort that angina causes.
You should take this medicine at the first sign of chest pain. If the first tablet does not work, you can take a second tablet after 5 minutes. However, if your chest pain does not go away after 15 minutes, you should get urgent medical attention. This could be a sign of a heart attack. Liras GTN 2.6 Tablet CR also helps prevent chest pain if taken before exercising or doing other strenuous activities.

Side effects of Liras GTN Tablet CR

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Liras GTN

Blurred vision
Decreased blood pressure
Dizziness
Headache
Increased heart rate
Lightheadedness
Paresthesia (tingling or pricking sensation)

How to use Liras GTN Tablet CR

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Liras GTN 2.6 Tablet CR may be taken with or without food, but it is better to take it at a fixed time.

How Liras GTN Tablet CR works

Liras GTN 2.6 Tablet CR is a nitrate. It works by relaxing the blood vessels and increasing the supply of blood and oxygen to the heart while reducing its work load, thereby preventing/treating attacks of angina (chest pain).

Safety advice

Alcohol

UNSAFE

Consuming alcohol while taking Liras GTN 2.6 Tablet CR may cause symptoms such as flushing, increased heart beat, nausea, thirst, chest pain and low blood pressure (Disulfiram reaction).

Pregnancy

SAFE IF PRESCRIBED

Liras GTN 2.6 Tablet CR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding

SAFE IF PRESCRIBED

Liras GTN 2.6 Tablet CR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving

UNSAFE

Liras GTN 2.6 Tablet CR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney

SAFE IF PRESCRIBED

Liras GTN 2.6 Tablet CR is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Liras GTN 2.6 Tablet CR may not be needed in these patients. Please consult your doctor.

Liver

CONSULT YOUR DOCTOR

There is limited information available on the use of Liras GTN 2.6 Tablet CR in patients with liver disease. Please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Liras GTN 2.6 Tablet CR

₹5.0/Tablet CR

Monit GTN 2.6 Tablet CR

Intas Pharmaceuticals Ltd

₹6.9/tablet cr

50% costlier

Myonit SR 2.6 Tablet

Troikaa Pharmaceuticals Ltd

₹7.77/tablet cr

69% costlier

Nitrolong 2.6 Tablet CR

Mankind Pharma Ltd

₹6.12/tablet cr

33% costlier

GTN Sorbitrate CR 2.6 Tablet

Abbott L

₹6.93/tablet cr

51% costlier

Ntgn 2.6 Tablet CR

C M R Life Sciences

₹5.5/tablet cr

20% costlier

View all substitutes

Quick tips

Liras GTN 2.6 Tablet CR may cause dizziness or sleepiness. Do not drive or do anything that requires concentration until you know how it affects you.
Do not consume alcohol while taking Liras GTN 2.6 Tablet CR as it may cause increased dizziness.
It may cause headaches which usually go away after a few days of continued treatment. Inform your doctor if it persists.
You may develop tolerance to Liras GTN 2.6 Tablet CR with time, meaning that the same dose may be less effective next time. Follow the prescribed dosing schedule to avoid this.
Stop taking medications (prescribed for erectile dysfunction) like sildenafil or tadalafil while on treatment with Liras GTN 2.6 Tablet CR as it may cause low blood pressure.

Fact Box

Chemical Class

Nitrates {Short acting}

Habit Forming

Therapeutic Class

CARDIAC

Action Class

NO Donors

Patient concerns

What is heart attack? When heart attack coming?

Dr. Nabajit Talukdar

Interventional Cardiology

Related to chest pain angina commonly

Recwntly have heart attack 1 month ago . Can drive 2 wheeler

Dr. Nabajit Talukdar

Interventional Cardiology

can do if no angina etc

Related ayurvedic ingredients

Arjuna

Top Cardiologists

Dr. Manjinder Sandhu

MBBS, MD, DNB, DM, Fellowship, Fellowship

4.7 ★

Dr. Balbir Singh

MBBS, MD, DM, Fellowship, Fellowship

4.8 ★

Dr. Rajneesh Kapoor

MBBS, MD, DNB

5 ★

Dr. (Col.) Balbir Kalra

MBBS, MD, DM

4.7 ★

Dr. R. R. Kasliwal

MBBS, MD, DM, Fellowship

4.7 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Michel T, Hoffman BB. Treatment of Myocardial Ischemia and Hypertension. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 747-55.
Katzung BG, Chatterjee K. Vasodilator & the Treatment of Angina Pectoris. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 191, 195-97.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 986-88.
Nitroglycerin Sublingual Tablets. New York, New York: Parke-Davis; 2014. [Accessed 20 Mar. 2019] (online) Available from:
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Nitroglycerin. [Updated 2018 Oct 31]. [Accessed 19 Feb. 2020] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). Nitroglycerin. [Accessed 19 Mar. 2019] (online) Available from:
Kim KH, Kerndt CC, Adnan G, et al. Nitroglycerin. [Updated 2022 Sep 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. [Accessed 02 Aug. 2023] (online) Available from:

Marketer details

Name: Liras Pharmaceutical LLP

Address: AL ARSH BUILDING,OLAVANNA,CALICUT

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.